Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons, appearance of Lewy bodies and presence of neuroinflammation. No treatments currently exist to prevent PD or delay its progression, and dopaminergic substitution treatments just rel...
Main Authors: | Elisa Storelli, Niccolò Cassina, Emanuela Rasini, Franca Marino, Marco Cosentino |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00013/full |
Similar Items
-
Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
by: Natasa Kustrimovic, et al.
Published: (2018-07-01) -
Th17 Lymphocytes in Respiratory Syncytial Virus Infection
by: Rizgar A. Mageed, et al.
Published: (2013-03-01) -
Regulatory T lymphocytes/Th17 lymphocytes imbalance in autism spectrum disorders: evidence from a meta-analysis
by: Pierre Ellul, et al.
Published: (2021-10-01) -
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
by: Anna Tosi, et al.
Published: (2021-12-01) -
IL-17-Producing Regulatory T lymphocytes – Suppressors or Effectors?
by: E. M. Kuklina, et al.
Published: (2023-11-01)